Brunswick vs China Yuchai International
BC and CYD side by side, both in industrial and commercial machinery and computer equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BC and CYD compare
China Yuchai International grew revenue faster over the last twelve months (28.9% versus 10.4% for Brunswick).
Brunswick keeps more of each dollar of sales as profit, with a net margin of 3.7% compared with 2.2% at China Yuchai International.
Brunswick pays a dividend yielding 2.2%; China Yuchai International does not pay one.
China Yuchai International scores higher on the StockData Score (12 against 11 for Brunswick), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BC | CYD |
|---|---|---|
| Size and price | ||
| Market cap | $5.1B | – |
| Share price | $78.38 | $21.83 |
| Change, 1 year | 22.5% | −45.4% |
| Change, 5 years | −21.7% | 80.3% |
| Beta (5Y) | 1.18 | 0.99 |
| Employees | 14K | 945 |
| StockData Score | ||
| Total score | 11 | 12 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 5 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 3 | 5 (better) |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 24.2× | – |
| P/S | 0.9× | – |
| P/B | 3.0× | – |
| EV/EBITDA | 10.9× | – |
| P/FCF | 13.7× | – |
| FCF yield | 7.3% | – |
| Fair value | $72.72 | – |
| Margin of safety | −7.8% | – |
| Growth | ||
| Revenue growth (TTM) | 10.4% | 28.9% (better) |
| Revenue growth, 5Y average | 4.3% (better) | 3.7% |
| Net income growth (TTM) | – | 66.3% |
| EPS growth (TTM) | – | 74.4% |
| EPS growth, 5Y average | – | 1.3% |
| Profitability | ||
| Gross margin | 26.2% (better) | 16.5% |
| Operating margin | 5.7% (better) | 4.4% |
| Net margin | 3.7% (better) | 2.2% |
| FCF margin | 6.5% | 9.1% (better) |
| Return on equity | 12.7% (better) | 5.7% |
| Return on invested capital | 8.2% | 15.8% (better) |
| Financial health | ||
| Debt / equity | 1.18 | 0.21 (better) |
| Net debt / EBITDA | 2.78 (better) | −3.06 |
| Interest coverage | 3.3× | 17.7× (better) |
| Current ratio | 1.51 (better) | 1.39 |
| Altman Z-score | 3.12 | – |
| Piotroski F-score | 5 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 2.2% | – |
| Payout ratio | 53.9% | – |
| Years of dividend growth | 13 | – |
| Dividend growth, 5Y average | 11.7% | – |
| Buyback yield | 1.5% | – |
| Shareholder yield | 3.7% | – |
| Ownership | ||
| Held by institutions | 106% | 22.6% |
| Held by insiders | 1.5% | 20.1% |
| Insider net buying, 12 months | −$11.2M | −$1.6M (better) |
| Superinvestors holding | 2 (better) | 1 |
| Short interest, % of float | 8.6% | – |
Go deeper
- BC stock overview
- BC income statement
- BC valuation and score
- CYD stock overview
- CYD income statement
- CYD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.